Boardroom Alpha
Meeting calendar
COCO · Annual meeting · Wednesday, June 3, 2026

Vita Coco Company Inc

3 nominees · 3 ballot items.

Three proposals: (1) election of three Class II directors (Shelley Broader, Michael Kirban, Kenneth Sadowsky); (2) ratification of Deloitte & Touche LLP as independent auditors for fiscal 2026; and (3) an advisory (non-binding) vote to approve named executive officer compensation (say-on-pay).

Market cap
$4.2B
1Y TSR
+99.4%
Board grade
B+
Record date
Apr 7, 2026
Filing
DEF 14A
Meeting concluded · Jun 3, 2026

Follow how the vote landed and what changed on Vita Coco Company Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect Shelley Broader, Michael Kirban, and Kenneth Sadowsky as Class II Directors to serve until the 2029 Annual Meeting.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This non-binding proposal asks shareholders to approve, on an advisory basis, the compensation paid to Vita Coco’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis and accompanying tables. Management is seeking shareholder approval to confirm that the company’s pay practices — a mix of base salary, annual cash incentives tied to Adjusted EBITDA and Net Revenue, and long-term equity (RSUs, options, PSUs) with performance vesting and an ESG modifier — are appropriate and properly align management incentives with shareholder interests. The advisory vote is part of Vita Coco’s regular corporate governance program and is explicitly non-binding; however, the Board and Compensation Committee state they will consider the vote’s outcome and shareholder feedback when making future compensation decisions. Company-specific context includes strong 2025 financial performance (18% net sales growth to $610 million, Adjusted EBITDA of $98 million) that produced a Corporate Performance Factor of 178.3% and resulted in significant 2025 bonus payouts and the Compensation Committee’s determination that certain multi-year performance awards met vesting thresholds. Management emphasizes that a significant portion of executive pay is at-risk and linked to multi-year performance goals to promote long-term value creation and retention. The Board recommends a FOR vote, citing alignment with performance and governance practices such as independent committee oversight, use of an independent compensation consultant, stock ownership guidelines, clawback policy, and no single-trigger change-in-control benefits. Key risks and controversies include the non-binding nature of the vote (limiting direct shareholder control), the significant realized payouts in a year of strong stock performance which some investors may view as high relative to peer benchmarks, and the presence of investor-nominated directors under the Investor Rights Agreement which shapes board composition and oversight. In sum, the proposal is a routine advisory confirmation of pay practices but one that provides the Board with shareholder feedback on the company’s compensation approach and will inform future compensation governance decisions.

Director elections

Nominees on the ballot3

Independent
Tenure on this board
0.5 yrs
Also a director at
Inspire Medical Systems Inc (INSP)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.8.6%4,906,588$235M
2FMR LLC7.0%4,007,656$192M
3WASATCH ADVISORS LP6.4%3,675,489$176M
4VANGUARD CAPITAL MANAGEMENT LLC3.7%2,091,968$100M
5WELLINGTON MANAGEMENT GROUP LLP3.2%1,835,219$88M
6STATE STREET CORP3.0%1,728,998$83M
7DRIEHAUS CAPITAL MANAGEMENT LLC2.7%1,523,647$73M
8BlackRock, Inc.2.3%1,335,667$64M
9WESTFIELD CAPITAL MANAGEMENT CO LP2.0%1,151,933$55M
10GEODE CAPITAL MANAGEMENT, LLC2.0%1,137,673$55M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Vita Coco Company Inc 2026 annual meeting?
Vita Coco Company Inc (COCO) holds its 2026 annual shareholder meeting on Wednesday, June 3, 2026.
What is the record date for the Vita Coco Company Inc 2026 meeting?
The record date for the Vita Coco Company Inc 2026 meeting is Tuesday, April 7, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Vita Coco Company Inc's 2026 meeting?
The board is presenting 3 director nominees at the Vita Coco Company Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Vita Coco Company Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Vita Coco Company Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer